You May Also Like

Pharyngeal Co-Infections with Monkeypox Virus and Group A Streptococcus, United States, 2022
Cite
CITE Title : Pharyngeal Co-Infections with Monkeypox Virus and Group A Streptococcus, United States, 2022 Personal Author(s) : Kaiser, Robyn M.;Cash-Goldwasser, Shama;Lehnertz, Nicholas;Griffith, Jayne;Ruprecht, Alison;Stanton, John;Feldpausch, Amanda;Pavlick, Jessica;Bruen, Charles A.;Perez-Molinar, David;Peglow, S. Rebecca;Akinsete, Omobosola O.;Morris, Sapna Bamrah;Raizes, Elliot;Gregory, Christopher;Lynfield, Ruth; Published Date : 9 2023;9-2023; Source : Emerg Infect Dis. 2023; 29(9):1855-1858 URL : https://stacks.cdc.gov/view/cdc/133588 Kaiser, Robyn M. et al. (2023). Pharyngeal Co-Infections with Monkeypox Virus and Group A Streptococcus, United States, 2022. 29(9). Kaiser, Robyn M. et al. "Pharyngeal Co-Infections with Monkeypox Virus and Group A Streptococcus, United States, 2022" 29, no. 9 (2023) Kaiser, Robyn M. et al. "Pharyngeal Co-Infections with Monkeypox Virus and Group A Streptococcus, United States, 2022" vol. 29, no. 9, 2023 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 1.09 MB]
Personal Author:
Kaiser, Robyn M. ;
Cash-Goldwasser, Shama
...
9 2023 | Emerg Infect Dis. 2023; 29(9):1855-1858
Description:
We report 2 cases of pharyngeal monkeypox virus and group A Streptococcus co-infection in the United States. No rash was observed when pharyngitis sym...
File Type:
[PDF - 1.09 MB]
File Type:
[PDF - 1.09 MB]

Interim clinical guidance for the treatment of monkeypox
Cite
CITE Title : Interim clinical guidance for the treatment of monkeypox Corporate Authors(s) : National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Published Date : June 10, 2022 URL : https://stacks.cdc.gov/view/cdc/118351 National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. (2022). Interim clinical guidance for the treatment of monkeypox. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. "Interim clinical guidance for the treatment of monkeypox" (2022) National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. "Interim clinical guidance for the treatment of monkeypox" , 2022 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 101.95 KB]
:
National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
June 10, 2022
Description:
Many individuals infected with monkeypox virus have a mild, self-limiting disease course in the absence of specific therapy. However, the prognosis fo...
File Type:
[PDF - 101.95 KB]
File Type:
[PDF - 101.95 KB]